« Closing Gap Between Pharma R&D and Social Benefits | Main | The CBO Says Generics Saved Medicare Part D $33 B »
Not surprisingly, the market has responded positively to the news that Crucell will be purchased by J&J to bolster the latter's position in the booming vaccine market.
Here's story on Crucell stock price run up from Seeking Alpha and more on J&J's move into vaccine segment from Burrill Report also in Seeking Alpha.
Posted by Bruce Lehr September 18th 2010
| | |
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0134877eed91970c
Listed below are links to weblogs that reference Crucell Stock Up on J&J Takeover News:
The comments to this entry are closed.
Comments